Citius Oncology, Inc. CTOR Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s total equity?
- Citius Oncology, Inc. (CTOR) reported total equity of $35.27M in Q1 2026.
- How has Citius Oncology, Inc.'s total equity changed year-over-year?
- Citius Oncology, Inc.'s total equity decreased by 1.0% year-over-year, from $35.64M to $35.27M.
- What is the long-term trend for Citius Oncology, Inc.'s total equity?
- Over 4 years (2021 to 2025), Citius Oncology, Inc.'s total equity has grown at a 716.1% compound annual growth rate (CAGR), from -$10.11K to $44.87M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.